Igor D. Grachev

1. Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
   2018/12/15 by Ralf Reilmann, Andrew McGarry, Igor D. Grachev +146 · 1 citation
   Medicine · Neuroscience · #Amyotrophic Lateral Sclerosis Research #Genetic Neurodegenerative Diseases #Neurological disorders and treatments